1. The first report of CADASIL in Peru: Olfactory dysfunction on initial presentation
- Author
-
Danny Moises Barrientos-Iman, Ivan Cornejo-Herrera, Mario Cornejo-Olivas, Karina Milla-Neyra, Miguel Inca-Martinez, Carlos Cosentino, and Anastasia Vishnevetsky
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,CADASIL ,Olfaction ,030105 genetics & heredity ,Olfactory dysfunction ,lcsh:RC346-429 ,03 medical and health sciences ,0302 clinical medicine ,Hyposmia ,NOTCH3 ,Peru ,medicine ,Cognitive decline ,Stroke ,lcsh:Neurology. Diseases of the nervous system ,Genetic testing ,Total anosmia ,medicine.diagnostic_test ,business.industry ,Vascular disease ,South America ,medicine.disease ,Neurology ,Original Article ,medicine.symptom ,business ,030217 neurology & neurosurgery ,MRI - Abstract
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is a rare, heritable, small vessel vascular disease caused by mutations in the Notch3 gene that is characterized by migraines, subcortical vascular events, cognitive decline, and mood disturbances. However, many CADASIL cases present with unusual symptoms such as status epilepticus, a movement disorder, or sensory dysfunction. This study describes the clinical, genetic, and radiologic characteristics of a Peruvian family with CADASIL in which multiple family members presented with severe olfactory deficits. Seven members of the family have symptoms suggestive of CADASIL, with genetic testing revealing R133C mutations in the two patients who underwent genetic testing. Cognitive testing and olfactory identification testing (Smell Identification Test) were performed in three CADASIL patients revealing total anosmia in two tested patients and severe hyposmia in the other. Olfactory dysfunction has been associated with various neurologic and psychiatric conditions, though few studies have linked it with neurovascular disorders such as CADASIL. This first reported case of CADASIL in Peru emphasizes that symptomatic olfactory dysfunction may be an unusual presentation of CADASIL and that olfactory dysfunction is important to evaluate in CADASIL patients., Highlights • The first reported family with CADASIL in Peru harbors a R133C mutation in the Notch3 gene. • Two members of the same family with CADASIL presented with complaints of symptomatic olfactory dysfunction. • This case of CADASIL in Peru emphasizes that symptomatic olfactory dysfunction may be an unusual presentation of CADASIL.
- Published
- 2016
- Full Text
- View/download PDF